Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-23-011376
Filing Date
2023-03-31
Accepted
2023-03-31 16:10:27
Documents
21

Document Format Files

Seq Description Document Type Size
1 DEF 14A flgt-20230331.htm   iXBRL DEF 14A 1609168
2 GRAPHIC img232161658_0.jpg GRAPHIC 75618
3 GRAPHIC img232161658_1.jpg GRAPHIC 18327
4 GRAPHIC img232161658_2.jpg GRAPHIC 24975
5 GRAPHIC img232161658_3.jpg GRAPHIC 26522
6 GRAPHIC img232161658_4.jpg GRAPHIC 23578
7 GRAPHIC img232161658_5.jpg GRAPHIC 65833
8 GRAPHIC img232161658_6.jpg GRAPHIC 78622
  Complete submission text file 0000950170-23-011376.txt   3684491

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT flgt-20230331_pre.xml EX-101.PRE 5768
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT flgt-20230331.xsd EX-101.SCH 4398
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT flgt-20230331_def.xml EX-101.DEF 4231
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT flgt-20230331_lab.xml EX-101.LAB 9141
15 EXTRACTED XBRL INSTANCE DOCUMENT flgt-20230331_htm.xml XML 513760
Mailing Address 4978 SANTA ANITA AVENUE, SUITE 205 TEMPLE CITY CA 91780
Business Address 4978 SANTA ANITA AVENUE, SUITE 205 TEMPLE CITY CA 91780 626-350-0537
Fulgent Genetics, Inc. (Filer) CIK: 0001674930 (see all company filings)

EIN.: 812621304 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37894 | Film No.: 23787695
SIC: 8071 Services-Medical Laboratories